Table 2. Patients’ demographics and clinical results of CLEAN-NET for gastric SMTs (N=36).
| Variables | Results |
|---|---|
| Gender (male/female) | 21/15 |
| Age (average, min–max) | 59.9 [25–87] |
| ASA physical status classification (I/II/III/IV/V/VI) | 15/21/0/0/0/0 |
| Growth pattern (intraluminal/extraluminal) | 33/3 |
| Tumor size (average, min–max) | 31.3 [15–63] mm |
| Dell (+/−) | 9/27 |
| Tumor location | Shown in Figure 3 |
| Operation time (average, min–max) | 112.7 (30–198) min |
| Blood loss (average, min–max) | 8.7 (0–135) g |
| Margin negative | 36 (100%) |
| Pathological diagnosis (n) | GIST: 27; schwannoma: 5; aberrant pancreas: 2; leiomyoma: 1; hamartoma: 1 |
| Postoperative complications | 1 (2.8%) gastroparesis |
| Recurrence | 0 (0%) |
| Follow-up period (days) | 1,387 [33–3,294] |
CLEAN-NET, combination of laparoscopic and endoscopic approaches for neoplasia with non-exposure technique; SMTs, submucosal tumors.